Exit events / 29
#29
| id | 29 |
|---|---|
| company_id | 2137 |
| event_type | stock_merger |
| event_date | 2026-05-31 |
| counterparty_company_id | 2136 |
| successor_company_id | — |
| deal_value_usd | — |
| deal_value_basis | — |
| notes | Rallybio Corporation (2136, NASDAQ: RLYB) and Avenzo Therapeutics (2137) announced a merger agreement to advance next-generation oncology... |
| source_urls | ["https://www.businesswire.com"] |
| payload | {} |
| entered_by_person_id | 480 |
| entered_at | 2026-06-02T16:35:58.860324+00:00 |
| data_source | Business Wire 2026-05-31 (inbox signal 17) |
| data_confidence | web_search |